Upper Gastrointestinal Disease
Conditions
Interventions
Experimental group:XZING-W200B
Sponsors
Nanfang Hospital, Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years, without gender limitation; 2. Gastroscopic diagnosis and/or treatment are needed during gastrointestinal emergency and surgery; 3. Participate in the clinical trial voluntarily with the signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindications to upper gastrointestinal endoscopy: (1) Those with thoracic and abdominal aortic aneurysms; (2) Those with a high degree of spinal deformity; (3) Patients with severe cardiovascular and cerebrovascular diseases; (4) Severe cardiopulmonary insufficiency is expected to be unable to tolerate gastroscopy; (5) Combined with systemic hemorrhagic diseases, or those with abnormal coagulation function and bleeding tendency; (6) Those with mental illness or severe intellectual disability who cannot cooperate with endoscopy. 2. Pregnant and lactating women; 3. Those who participated in other clinical trials one month before screening; 4. Those who have a history of allergy to anesthetics in the past; 5. Patients who are judged by the investigator to be unsuitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Timely detection of lesions and evaluation on handling capability; | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation on clinical operational experience ; | — |
Countries
China
Contacts
Public ContactLiu Side
Nanfang Hospital, Southern Medical University
Outcome results
None listed